Hypoxia modulation of peroxisome proliferator‐activated receptors (PPARs) in human glioblastoma stem cells. Implications for therapy

Gliobastoma (GB), the most common adult brain tumor, infiltrates normal brain area rendering impossible the complete surgical resection, resulting in a poor median survival (14–15 months), despite the aggressive multimodality treatments post‐surgery, such as radiation and chemo‐therapy. GB is characterized by hypoxic and necrotic regions due to a poorly organized tumor vascularization, leading to inadequate blood supply and consequently to hypoxic and necrotic areas. We have previously shown that, under hypoxia GB primary cells increased the expression of stemness markers as well as the expression of the nuclear receptor peroxisome proliferator‐activated receptor α (PPARα) and also the crucial role played by PPARs in mouse neural stem cells maintenance and differentiation. Due to the importance of lipid signaling in cell proliferation and differentiation, in this work, we analyzed the expression of PPARs in GB neurospheres both in normoxic and hypoxic conditions. The results obtained suggest a differential regulation of the three PPARs by hypoxia, thus indicating a possible therapeutic strategy to counteract GB recurrencies. J. Cell. Biochem. 113: 3342–3352, 2012. © 2012 Wiley Periodicals, Inc.

[1]  P. Thérond.  Release and transportation of Hedgehog molecules. , 2012, Current opinion in cell biology.

[2]  A. Giordano,et al.  Hypoxia induces peroxisome proliferator‐activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells , 2011, Journal of cellular biochemistry.

[3]  Y. Huang,et al.  PPARγ-mediated advanced glycation end products regulate neural stem cell proliferation but not neural differentiation through the BDNF-CREB pathway. , 2011, Toxicology letters.

[4]  J. Moran,et al.  Cholesterol Metabolism Is Required for Intracellular Hedgehog Signal Transduction In Vivo , 2011, PLoS genetics.

[5]  A. Cimini,et al.  Signal transduction pathways involved in PPARβ/δ‐induced neuronal differentiation , 2011, Journal of cellular physiology.

[6]  R. Ippoliti,et al.  Innovative Therapies against Human Glioblastoma Multiforme , 2011, ISRN oncology.

[7]  E. Bar,et al.  Glioblastoma, Cancer Stem Cells and Hypoxia , 2011, Brain pathology.

[8]  J. García-Verdugo,et al.  Peroxisome proliferator‐activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo , 2011, Glia.

[9]  C. Eberhart,et al.  Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. , 2010, The American journal of pathology.

[10]  P. LoRusso,et al.  Review: Targeting the Hedgehog pathway in cancer , 2010, Therapeutic advances in medical oncology.

[11]  A. Cimini,et al.  PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors , 2010, PPAR research.

[12]  A. Sotgiu,et al.  Lipid Metabolism Impairment in Human Gliomas: Expression of Peroxisomal Proteins in Human Gliomas at Different Grades of Malignancy , 2010, International journal of immunopathology and pharmacology.

[13]  J. Engh,et al.  Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α , 2009, Oncogene.

[14]  D. Panchision,et al.  The role of oxygen in regulating neural stem cells in development and disease , 2009, Journal of cellular physiology.

[15]  V. Amberger-Murphy.  Hypoxia helps glioma to fight therapy. , 2009, Current cancer drug targets.

[16]  R. Jensen,et al.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target , 2009, Journal of Neuro-Oncology.

[17]  K. Camphausen,et al.  Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro , 2009, Molecular Cancer Research.

[18]  L. Denaro,et al.  Hypoxia and HIF1α Repress the Differentiative Effects of BMPs in High‐Grade Glioma , 2009, Stem cells.

[19]  A. Cimini,et al.  Biomolecular characterization of human glioblastoma cells in primary cultures: Differentiating and antiangiogenic effects of natural and synthetic PPARγ agonists , 2008, Journal of cellular physiology.

[20]  Franklyn A Howe,et al.  An investigation of human brain tumour lipids by high‐resolution magic angle spinning 1H MRS and histological analysis , 2008, NMR in biomedicine.

[21]  X. Bian,et al.  Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. , 2008, Cancer letters.

[22]  A. Cimini,et al.  Emerging Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in the Regulation of Neural Stem Cells Proliferation and Differentiation , 2008, Stem Cell Reviews.

[23]  M. Denti,et al.  RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: A model system to study PMP70 function , 2008, Neurochemistry International.

[24]  U. Lendahl,et al.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.

[25]  Chulhee Choi,et al.  Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species. , 2008, Immunology letters.

[26]  Wei Zhang,et al.  Leptin Increases Adult Hippocampal Neurogenesis in Vivo and in Vitro* , 2008, Journal of Biological Chemistry.

[27]  Yiting Cao,et al.  Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  F. Guillemot.  Cell fate specification in the mammalian telencephalon , 2007, Progress in Neurobiology.

[29]  A. Cimini,et al.  PPARs Expression in Adult Mouse Neural Stem Cells: Modulation of PPARs during Astroglial Differentiaton of NSC , 2007, PPAR research.

[30]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[31]  G. Doherty.  Developmental switch in the effects of TNFα on ventral midbrain dopaminergic neurons , 2007, Neuroscience Research.

[32]  Lee L. Rubin,et al.  Targeting the Hedgehog pathway in cancer , 2006, Nature Reviews Drug Discovery.

[33]  T. Mayumi,et al.  Peroxisome Proliferator-activated Receptor γ-mediated Regulation of Neural Stem Cell Proliferation and Differentiation* , 2006, Journal of Biological Chemistry.

[34]  Béatrice Desvergne,et al.  From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. , 2006, Progress in lipid research.

[35]  U. Edvardsson,et al.  PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes Published, JLR Papers in Press, November 10, 2005. , 2006, Journal of Lipid Research.

[36]  R. Roberts,et al.  Low O2 tensions and the prevention of differentiation of hES cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Lixin Sun,et al.  Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. , 2004, The Journal of clinical investigation.

[38]  N. Frossard,et al.  Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin‐1β through concerted regulation of a GRE‐like and an NF‐κB response element , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  B. Novitch,et al.  Vertebrate neurogenesis is counteracted by Sox1–3 activity , 2003, Nature Neuroscience.

[40]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[41]  Christian Wolfrum,et al.  Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Maccarone,et al.  Interleukin 1-beta modulates the effects of hypoxia in neuronal culture , 2000, Journal of Neuroimmunology.

[43]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: insight into multiple cellular functions. , 2000, Mutation research.

[44]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.

[45]  Romanelli,et al.  A new collection method for the evaluation of nasal mucus proteins , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[46]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.

[47]  A. Mahfoudi,et al.  Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Gustafsson,et al.  Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[50]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[51]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[52]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[53]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[54]  K. Zänker,et al.  MCP-1 induces migration of adult neural stem cells. , 2004, European journal of cell biology.

[55]  Kelvin K. W. Chan,et al.  The statins as anticancer agents. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  J. Berger,et al.  The mechanisms of action of PPARs. , 2002, Annual review of medicine.

[57]  H. Isbell.  METABOLISM OF NEOPLASTIC TISSUE , 2001 .

[58]  F. Spener,et al.  Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. , 1953, Cancer research.

[60]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. III. Diphosphopyridine nucleotide requirements for oxidations by mitochondria of neoplastic and non-neoplastic tissues. , 1953, Cancer research.